Clinical trial
A Study of Adalimumab for the Induction of Clinical Remission in Japanese…
NCT00445939 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00445939 |
|---|---|
| Title | A Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease |
| Official title | A Multi-Center, Randomized, Double-blind, Placebo-controlled Study of Adalimumab for the Induction of Clinical Remission in Japanese Subjects With Crohn's Disease |
| Lead sponsor | Abbott, Industry |
| Collaborators | Abbott Japan Co.,Ltd Industry Eisai Co., Ltd. |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Crohn's Disease |
| Intervention type | Biological |
| Interventions | adalimumab, placebo |
| Enrollment | 90 |
| Start date | Feb 1, 2007 |
| Primary completion | Dec 1, 2007 |
| First posted | Mar 9, 2007 |
| Last update posted | Jun 27, 2011 |
| Countries | Japan |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: